Syphilis Testing Market Research Report: By Sample Type (Blood, Serum, Plasma, Cerebrospinal Fluid), By Technology (Enzyme Immunoassay (EIA), Chemiluminescence Immunoassay (CLIA), Rapid Plasma Reagin (RPR) Test, Treponema Pallidum Particle Agglutination (TPPA) Test, Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test), By Product Type (Automated Syphilis Testing Systems, Manual Syphilis Testing Kits, Point-of-Care Syphilis Testing Devices), By Application (Diagnostic Testing, Screening and Surveillance, Monitoring of Treatment Respons

Global Syphilis Testing Market Overview

As per MRFR analysis, the Syphilis Testing Market Size was estimated at 1.0 (USD Billion) in 2022. 

The Syphilis Testing Market Industry is expected to grow from 1.03(USD Billion) in 2023 to 1.4 (USD Billion) by 2032. The Syphilis Testing Market CAGR (growth rate) is expected to be around 3.46% during the forecast period (2024 - 2032).

Key Syphilis Testing Market Trends Highlighted

Emerging molecular diagnostics and advancements in serological testing methods drive the Syphilis Testing Market. The increasing prevalence of sexually transmitted infections (STIs), including syphilis, fuels market growth. Furthermore, advancements in point-of-care (POC) testing offer rapid and accurate syphilis detection, enhancing market adoption.Government initiatives and public health campaigns to combat STIs create opportunities for market expansion. Collaborations between governments and healthcare organizations to provide affordable syphilis testing and treatment programs drive market growth. Additionally, technological advancements in automation and multiplex testing systems streamline testing procedures, reducing turnaround time and costs.The market has witnessed the emergence of non-invasive testing methods, such as oral fluid and urine testing, which provide convenient and less invasive alternatives to traditional blood tests. This trend expands testing accessibility and facilitates early detection and treatment of syphilis, contributing to market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Syphilis Testing Market Drivers

Rising Incidence of Syphilis Infections

The growth in the Syphilis Testing Market Industry is primarily driven by the increasing prevalence of syphilis infections. Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. It can affect both men and women and if left untreated, it can cause serious health problems. According to the World Health Organization, there were an estimated 6.3 million new cases of syphilis in 2020. The growing number of infections is a result of several factors, including unprotected sex, lack of information about the disease and limited access to medical help.Because the number of people suffering from syphilis continues to grow, the demand for syphilis testing is expected to increase.

Technological Advancements in Syphilis Testing

Technological advancement in syphilis testing is driving the Syphilis Testing Market Industry. Conventionally, the Venereal Disease Research Laboratory and Treponema pallidum particle agglutination tests have been used to test syphilis for many years. These tests have been found to have some limitations, such as low sensitivity and specificity. However, over the years, new technologies for testing Syphilis have been developed which are more accurate.These technological tests include rapid point-of-care testing, nucleic acid amplification testing, and multiplex assays. Future growth in the Syphilis Testing Market Industry will depend on whether more people will adopt these new tests for syphilis or not.

Increasing Awareness about Syphilis

The Syphilis Testing Market Industry is further helped due to the growing awareness of the disease. A number of public health campaigns and programs are being run to prevent the disease and to educate the masses about the problems associated with the same. This growing awareness is creating a demand for more and more syphilis tests, thus contributing to the growth of the market. People are now more aware of the easy availability of testing facilities.The availability of self-test kits and other resources has made it easier and more confidential for people to get themselves tested. Thus, the Syphilis Testing Market Industry is being driven due to the increasing awareness created about the issue.

Syphilis Testing Market Segment Insights

Syphilis Testing Market Sample Type Insights

The report “Syphilis Testing Market Forecasts to 2032” provides an in-depth analysis of the Syphilis Testing Market. The market is segmented by sample type. Based on sample type, the market is segmented into whole blood, serum, plasma and cerebrospinal fluid. The whole blood segment is expected to hold the largest market share for 2023. The serum segment is expected to grow at the highest CAGR in the forecast period. The growth of the syphilis testing market can be attributed to increasing prevalence of syphilis, technological advancements in syphilis testing methods and rising awareness about syphilis testing.The market is also expected to benefit from the increasing availability of syphilis testing kits and the increasing number of diagnostic centers.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Syphilis Testing Market Technology Insights

Enzyme Immunoassay was the technology with the largest share in the Syphilis Testing Market in 2023 and is expected to continue to lead the market over the forecast period. EIA is a widely used technology due to its high sensitivity, specificity, and relatively low cost. Chemiluminescence Immunoassay is another common technology that provides the benefits of rapid results and automated testing. Rapid Plasma Reagin is a relatively simple and inexpensive test that is often used for screening purposes. Treponema Pallidum Particle Agglutination Test and Fluorescent Treponemal Antibody Absorption Test are more expensive confirmatory tests that are used to make a highly accurate diagnosis of syphilis.

Syphilis Testing Market Product Type Insights

The Syphilis Testing Market segmentation by Product Type presents valuable insights into the market dynamics. Automated Syphilis Testing Systems, Manual Syphilis Testing Kits, and Point-of-Care Syphilis Testing Devices represent the key product types. Automated Syphilis Testing Systems accounted for the largest revenue share in 2023, attributed to their high accuracy and efficiency in processing a large number of samples. The Syphilis Testing Market data shows that Automated Syphilis Testing Systems are expected to maintain their dominance throughout the forecast period, driven by advancements in technology and increased demand for automated solutions.Manual Syphilis Testing Kits are projected to witness steady growth, primarily due to their cost-effectiveness and availability in resource-limited settings. However, their market share is anticipated to decline gradually as automated systems become more prevalent. Point-of-Care Syphilis Testing Devices are gaining traction owing to their rapid turnaround time and convenience. The Syphilis Testing Market Statistics indicate that this segment is poised for significant growth, particularly in regions with limited access to laboratory infrastructure.By leveraging these insights, market players can strategize their product offerings and target specific segments to drive growth and capture a larger share of the Syphilis Testing Market industry.

Syphilis Testing Market Application Insights

The Syphilis Testing Market is segmented by application into diagnostic testing, screening and surveillance, and monitoring of treatment response. The diagnostic testing segment is expected to hold the largest market share in 2023 and is projected to continue to dominate the market throughout the forecast period. This is due to the increasing prevalence of syphilis, as well as the need for accurate and timely diagnosis to prevent serious complications. The screening and surveillance segment is expected to grow at a rapid pace due to the increasing adoption of syphilis screening programs in high-risk populations.The monitoring of the treatment response segment is expected to grow at a moderate pace due to the increasing use of serological tests to monitor the effectiveness of syphilis treatment.

Syphilis Testing Market End User Insights

The Syphilis Testing Market is segmented by end user into diagnostic laboratories, hospitals and clinics, research institutions, blood banks, and point-of-care facilities. Among these, diagnostic laboratories held the largest market share in 2023 and are expected to maintain their dominance throughout the forecast period. This is attributed to the increasing number of syphilis cases, growing awareness about the disease, and the availability of advanced testing technologies in diagnostic laboratories. Hospitals and clinics are also expected to witness significant growth in the coming years, owing to the increasing number of patients seeking syphilis testing and the rising prevalence of the disease in developing countries.Research institutions are also expected to contribute to the growth of the market, as they are involved in the development of new and innovative syphilis testing methods. Blood banks and point-of-care facilities are also expected to experience growth as they provide convenient and accessible testing options for patients.

Syphilis Testing Market Regional Insights

The Syphilis Testing Market is segmented by region into North America, Europe, APAC, South America and MEA. Among these regions, North America held the largest market share of 38.4% in 2023 and is expected to maintain its dominance throughout the forecast period. This can be attributed to the increasing prevalence of syphilis, coupled with the presence of a well-established healthcare infrastructure in the region. Europe is expected to follow North America in terms of market size, with a revenue share of approximately 30.5% in 2023. The market in APAC is anticipated to witness the highest growth rate over the forecast period, owing to the increasing awareness about syphilis and the availability of affordable testing options in the region.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Syphilis Testing Market Key Players And Competitive Insights

Key companies operating in the Syphilis Testing Market are continuously concentrating on gaining a competitive advantage by investing in research and development, expanding product offerings, and acquiring others. In addition, the major market players are adopting various growth strategies like collaboration, mergers and acquisitions, and joint ventures, which are expected to up the overall competition of the market in the coming years. However, the competitive landscape of the Syphilis Testing Market is anticipated to remain dynamic in the near future, as new players are due to enter the market with innovative solutions to compete with the established players.One of the leading players in the Syphilis Testing Market is Abbott Laboratories. The company offers a broad range of syphilis testing solutions, including rapid tests, automated immunoassays, and molecular diagnostics. Abbott Laboratories has a strong presence across the globe and is in a strong position to leverage the growing demand for syphilis testing. Further, the company is actively focusing on expanding its research and development activities, as it has recently introduced a range of new products to cater to the evolving demands of the market.A key player in the Syphilis Testing Market is Bio-Rad Laboratories, as well. The company provides an extensive product range for syphilis tests, including rapid tests, ELISA kits and molecular diagnostics. Bio-Rad Laboratories has an acute focus on innovation and puts considerable efforts towards offering high-quality products to cater to its client base. Additionally, with an established distribution network, the company is well-placed to meet the increasing demand for syphilis testing across both developed as well as emerging markets.

Key Companies in the Syphilis Testing Market Include

• Danaher


• Hologic


• Chembio Diagnostics


• QIAGEN


• BD


• DiaSorin


• Jant


• Siemens Healthineers


• HoffmannLa Roche


• Abbott


• Fujirebio


• CerTest Biotec


• BioRad Laboratories


• Luminex Corporation


• Meridian Bioscience

Syphilis Testing Market Industry Developments

The Syphilis Testing Market is expected to grow from USD 1.03 billion in 2023 to USD 1.4 billion by 2032, at a CAGR of 3.46%. The market growth is attributed to increasing prevalence of syphilis, technological advancements in testing methods, and rising awareness about the disease.Recent news developments include the launch of new rapid diagnostic tests for syphilis, such as the SD Bioline Syphilis 3.0 Rapid Test. This test provides results in 15 minutes, which is significantly faster than traditional tests. Additionally, there is growing interest in the use of point-of-care syphilis testing, which can be performed in non-traditional settings such as community clinics and pharmacies. This is expected to increase access to testing and improve the early detection and treatment of syphilis.

Syphilis Testing Market Segmentation Insights

Syphilis Testing Market Sample Type Outlook

• Blood


• Serum


• Plasma


• Cerebrospinal Fluid

Syphilis Testing Market Technology Outlook

• Enzyme Immunoassay (EIA)


• Chemiluminescence Immunoassay (CLIA)


• Rapid Plasma Reagin (RPR) Test


• Treponema Pallidum Particle Agglutination (TPPA) Test


• Fluorescent Treponemal Antibody Absorption (FTA-ABS) Test

Syphilis Testing Market Product Type Outlook

• Automated Syphilis Testing Systems


• Manual Syphilis Testing Kits


• Point-of-Care Syphilis Testing Devices

Syphilis Testing Market Application Outlook

• Diagnostic Testing


• Screening and Surveillance


• Monitoring of Treatment Response

 Syphilis Testing Market End User Outlook

• Diagnostic Laboratories


• Hospitals and Clinics


• Research Institutions


• Blood Banks


• Point-of-Care Facilities

Syphilis Testing Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa